Janssen H - Search Results

1

New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment.

Cowie MR, Filippatos GS, Alonso Garcia MLA, Anker SD, Baczynska A, Bloomfield DM, Borentain M, Bruins Slot K, Cronin M, Doevendans PA, El-Gazayerly A, Gimpelewicz C, Honarpour N, Janmohamed S, Janssen H, Kim AM, Lautsch D, Laws I, Lefkowitz M, Lopez-Sendon J, Lyon AR, Malik FI, McMurray JJV, Metra M, Figueroa Perez S, Pfeffer MA, Pocock SJ, Ponikowski P, Prasad K, Richard-Lordereau I, Roessig L, Rosano GMC, Sherman W, Stough WG, Swedberg K, Tyl B, Zannad F, Boulton C, De Graeff P. Cowie MR, et al. Among authors: janssen h. Eur J Heart Fail. 2017 Jun;19(6):718-727. doi: 10.1002/ejhf.809. Epub 2017 Mar 27. Eur J Heart Fail. 2017. PMID: 28345190 Free article. Review.

2

The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors.

Blind E, de Graeff PA, Meurs I, Holtkamp F, Baczynska A, Janssen H. Blind E, et al. Among authors: janssen h. Eur Heart J. 2015 Dec 27:ehv673. doi: 10.1093/eurheartj/ehv673. Online ahead of print. Eur Heart J. 2015. PMID: 26712836 No abstract available.

3

CardioPulse: The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors.

Blind E, de Graeff PA, Meurs I, Holtkamp F, Baczynska A, Janssen H. Blind E, et al. Among authors: janssen h. Eur Heart J. 2016 Feb 7;37(6):502-3. doi: 10.1093/eurheartj/ehv685. Eur Heart J. 2016. PMID: 26853264 No abstract available.

4

The European Medicines Agency's approval of new medicines for type 2 diabetes.

Blind E, Janssen H, Dunder K, de Graeff PA. Blind E, et al. Among authors: janssen h. Diabetes Obes Metab. 2018 Sep;20(9):2059-2063. doi: 10.1111/dom.13349. Epub 2018 May 30. Diabetes Obes Metab. 2018. PMID: 29740935 Free PMC article. Review.

5

Regulatory aspects of the development of drugs for metabolic bone diseases - FDA and EMA perspective.

Kehoe T, Blind E, Janssen H. Kehoe T, et al. Among authors: janssen h. Br J Clin Pharmacol. 2019 Jun;85(6):1208-1212. doi: 10.1111/bcp.13791. Epub 2018 Dec 3. Br J Clin Pharmacol. 2019. PMID: 30335197 Free PMC article. Review.

6

Regulatory Reply to the ATMOSPHERE Data Monitoring Committee.

Salmonson T, Janssen H, Sudhop T, Stahl E. Salmonson T, et al. Among authors: janssen h. N Engl J Med. 2016 Apr 21;374(16):1585-6. doi: 10.1056/NEJMc1603514. Epub 2016 Apr 4. N Engl J Med. 2016. PMID: 27043362 No abstract available.

7

Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs.

Mazzaglia G, Straus SMJ, Arlett P, da Silva D, Janssen H, Raine J, Alteri E. Mazzaglia G, et al. Among authors: janssen h. Drug Saf. 2018 Feb;41(2):191-202. doi: 10.1007/s40264-017-0604-4. Drug Saf. 2018. PMID: 29124666 Free PMC article.

8

Non-vitamin-K oral anticoagulants and laboratory testing: now and in the future: Views from a workshop at the European Medicines Agency (EMA).

Salmonson T, Dogné JM, Janssen H, Garcia Burgos J, Blake P. Salmonson T, et al. Among authors: janssen h. Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):42-47. doi: 10.1093/ehjcvp/pvw032. Epub 2016 Dec 25. Eur Heart J Cardiovasc Pharmacother. 2017. PMID: 28025213 Free PMC article. Review.

9

New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus.

Van der Schueren B, Vrijlandt P, Thomson A, Janssen H, Dunder K. Van der Schueren B, et al. Among authors: janssen h. Diabetologia. 2024 May 4. doi: 10.1007/s00125-024-06162-z. Online ahead of print. Diabetologia. 2024. PMID: 38702529 No abstract available.

10

Progression of the FIB-4 index among patients with chronic HCV infection and early liver disease.

Krassenburg LAP, Maan R, Puenpatom A, Erler NS, Welsch C, van Hees S, Cerrhoci O, Vermehren J, de Knegt RJ, Hansen BE, Zeuzem S, Vanwolleghem T, Janssen HLA, de Man RA, Feld JJ, van der Meer AJ. Krassenburg LAP, et al. Among authors: janssen hla. BMJ Open Gastroenterol. 2023 Dec 7;10(1):e001209. doi: 10.1136/bmjgast-2023-001209. BMJ Open Gastroenterol. 2023. PMID: 38637963 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,348 results

Search Page